Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$98.82 USD

98.82
666,765

+1.62 (1.67%)

Updated Nov 8, 2024 03:59 PM ET

After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical Services

Zacks News

Christopher Vargas headshot

3 Stocks to Consider as Retail Spending Slows

The stock market saw tepid movement Friday after the US struck a phase one deal with China.

McKesson, Walgreens Form JV for European Pharmaceutical Unit

The VA selects McKesson (MCK) as their prime pharmaceutical supplier.

LHC Group Set to Gain From Expansion of LifePoint Health JV

LHC Group (LHCG) expects approximately $5.4 million in annualized revenues from this transaction.

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

Here's Why You Should Hold on to Ecolab (ECL) Stock for Now

Ecolab (ECL) slashes 2019 EPS view owing to foreign exchange headwinds.

Company News for Dec 5, 2019

Companies In The News Are: HQY, CRM, CPB, RY

Here's Why You Should Hold on to HealthEquity (HQY) for Now

Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q3

Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.

HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of 113.64% and 3.29%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?

Sapna Bagaria headshot

Teladoc (TDOC) Up 73% Year to Date: Will the Rally Continue?

Teladoc's (TDOC) presence in the growing telehealth industry with many deal wins and international expansion is likely to drive long-term growth.

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

ERFSF or HQY: Which Is the Better Value Stock Right Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Down 5.3% Since Last Earnings Report: Can It Rebound?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q2

HealthEquity (HQY) gains from solid segmental contributions in second-quarter fiscal 2020.

HealthEquity Acquires WageWorks, To Make Notable Investments

HealthEquity (HQY) expects to complete its $80-100 million investment program within 24-36 months from now.

What's in the Cards for HealthEquity (HQY) in Q2 Earnings?

Higher revenues and possible margin expansion are likely to aid HealthEquity (HQY) in Q2 earnings.

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HealthEquity (HQY) Gains But Lags Market: What You Should Know

HealthEquity (HQY) closed at $58.62 in the latest trading session, marking a +0.15% move from the prior day.

HealthEquity (HQY) Stock Moves -0.51%: What You Should Know

In the latest trading session, HealthEquity (HQY) closed at $60.69, marking a -0.51% move from the previous day.

HealthEquity (HQY) Gains But Lags Market: What You Should Know

HealthEquity (HQY) closed at $68.50 in the latest trading session, marking a +1.41% move from the prior day.

HealthEquity (HQY) Stock Sinks As Market Gains: What You Should Know

HealthEquity (HQY) closed at $77.80 in the latest trading session, marking a -0.13% move from the prior day.

AMN or HQY: Which Is the Better Value Stock Right Now?

AMN vs. HQY: Which Stock Is the Better Value Option?

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

Is (HQY) Outperforming Other Medical Stocks This Year?